Shares of vaccine makers fell Monday following the resignation of FDA vaccine chief Peter Marks, according to CNBC. He criticized Health Secretary Robert F. Kennedy Jr.’s vaccine stance, saying Kennedy spread “misinformation and lies” and undermined public trust in immunization. Analysts warned that Marks’ departure could weaken the FDA’s scientific credibility and further strain the biotech sector.
